Physician profile
James W Genuario
NPI 1972600435
$719,502.40
in general payments reported to CMS, 2019-2025
8 companies · $150K in 2025
The $150K reported for 2025 was more than what 98% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $62K · 2021: $101K · 2022: $113K · 2023: $102K · 2024: $123K · 2025: $150K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $192K · Consulting Fee: $171K · Travel and Lodging: $8,196 · Food and Beverage: $3,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $192,179.85 |
| Consulting Fee | $171,175.00 |
| Travel and Lodging | $8,196.35 |
| Food and Beverage | $3,782.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $711,496.89 | 2019-2025 | Alphavent, Na, Iconix |
| Arthrex, INC. | $4,761.57 | 2019 | |
| Smith+Nephew, INC. | $2,367.11 | 2019 | |
| Gemini Mountain Medical, LLC | $643.77 | 2019-2023 | |
| Bioventus LLC | $121.01 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Ossur Americas, INC. | $88.16 | 2025 | Unloader One X |
| Organogenesis INC. | $23.89 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Genuario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.